This book offers an alternative to faith-dependent analytical approaches by explaining how original data can be transformed into cogent and compelling interpretations with analytical techniques that are straightforward and accessible to biomedical scientists. Other data-related topics covered in the book are the aesthetics of data or how beauty in data inspires, erroneous data by fraud or honest mistake and what role it plays in biomedical science, the difference between experimental and observational data, the issue of reproducibility of data, and the implications of focusing on original data for peer review leading to both publication and scientific funding. By considering these various subjects, this book has synthesized a philosophy for students to help them develop an effective and appropriate sensibility, for biomedical research investigators to guide them in their studies, for practitioners to assist them in making sense of the complex and largely opaque mechanisms in generating new knowledge for the benefit of their patients and for business professionals who would benefit from a thoughtful consideration of biomedical science.
I think it is worthwhile to indicate that the book may be useful to laypeople motivated to understand biomedical science. The book was written for intelligent and thoughtful readers and does not require an extensive biomedical science background.
Preface.
Chapter One Original Data.
Chapter Two Data Quality.
Chapter
Three Data Collection.
Chapter Four Data Analysis.
Chapter Five Aesthetics
of Data.
Chapter Six Erroneous Data.
Chapter Seven Data
Reproducibility.-Chapter Eight Converting Data into Interpretation.
Chapter
Nine Oral Presentation of Data.
Chapter Ten Evaluation of Data by Peer
Review.
Chapter Eleven The Value of Data.
Dr. David Kaplan graduated with A.B, Ph.D., and M.D. degrees from the University of Chicago. He was a pathology resident at Barnes and Jewish Hospitals and a postdoctoral fellow at Washington University. Since 1984 he served as a faculty member at Case Western Reserve University and an attending physician at University Hospitals Cleveland. In 2016 he founded a biotechnology company based on his invention of a powerful technology that enhanced the sensitivity of flow cytometric analysis. Dr. Kaplan has made many advancements throughout his scientific career including the first cloning of human influenza-specific cytotoxic T cells, the first gene transfer into human T cells, the first use of antisense transfection to inhibit expression of a protein to probe its function in the context of the human T cell, and the first demonstration of intercellular immunoregulation via cell surface receptors.
Lisainfo e-raamatute kohta